Jacob Steven Leach net worth and biography

Jacob Leach Biography and Net Worth

Director of Senestech

As the Chief Technology Officer at Dexcom, Jake is responsible for the leadership of scientific research, engineering, product development, and project management. Jake oversees the development of next generation products and leads a large organization of amazing people. His teams are responsible for delivering best in class glucose monitoring technology paired with an exceptional user experience.

Jake joined Dexcom in March 2004 to lead the development of sensor electronics which were part of the first generation Dexcom system. Jake has served in various roles within Dexcom including Senior Vice President of R&D, Senior Director of R&D, and Manager of Engineering.

From 1996 to 2004, Jake held positions in research and development at MiniMed and subsequently Medtronic Diabetes, focusing on the development of glucose sensing systems.

Jake holds a Bachelor of Science degree in Electrical Engineering with a minor in Biomedical Engineering from the University of California, Los Angeles.

What is Jacob Steven Leach's net worth?: The estimated net worth of Jacob Steven Leach is at least $968.56 thousand as of November 10th, 2025. Mr. Leach owns 331,697 shares of Senestech stock worth more than $968,555 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Leach may own. Learn More about Jacob Steven Leach's net worth.
How do I contact Jacob Steven Leach?: The corporate mailing address for Mr. Leach and other Senestech executives is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. Senestech can also be reached via phone at (928) 779-4143 and via email at [email protected]. Learn More on Jacob Steven Leach's contact information.
Has Jacob Steven Leach been buying or selling shares of Senestech?: Jacob Steven Leach has not been actively trading shares of Senestech during the last quarter. Most recently, on Wednesday, August 18th, Jacob Steven Leach bought 416 shares of Senestech stock. The stock was acquired at an average cost of $184.80 per share, with a total value of $76,876.80. Following the completion of the transaction, the director now directly owns 416 shares of the company's stock, valued at $76,876.80. Learn More on Jacob Steven Leach's trading history.
Are insiders buying or selling shares of Senestech?: In the last twelve months, insiders at the sold shares 1 times. They sold a total of 1 shares worth more than $2.75. The most recent insider tranaction occured on November, 14th when Director Matthew K Szot sold 1 shares worth more than $2.75. Insiders at Senestech own 5.3% of the company. Learn More about insider trades at Senestech.
Information on this page was last updated on 11/14/2025.

Jacob Steven Leach Insider Trading History at Senestech

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/18/2021	Buy	416	$184.80	$76,876.80	416
8/16/2021	Buy	416	$184.80	$76,876.80

Jacob Steven Leach Buying and Selling Activity at Senestech

Senestech Company Overview

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Today's Range

Now: $2.92

$2.87

$2.99

50 Day Range

MA: $3.43

$2.43

$4.64

2 Week Range

Now: $2.92

$1.30

$6.24

Volume

19,713 shs

Average Volume

80,203 shs

Market Capitalization

$15.24 million

P/E Ratio

N/A

Dividend Yield